Browsing: Opinion

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the…

ANAVEX LIFE SCIENCES CORP. (AVXL) filed an amended annual report to revise its assessment of internal control over financial reporting as of September 30, 2025. After a Special Committee review and the April 30, 2026 termination of the former CEO’s employment for Cause, management and the Audit Committee concluded a material weakness existed at September…

discourse in the last few weeks focusing on the issue of public perception of AI, and why it’s so negative. People polled indicate they hate AI more than ICE, and younger generations seem to have stronger negative opinions, even as many of them use the technology day to day.